106 related articles for article (PubMed ID: 2738885)
1. Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoids.
Dawson MI; Hobbs PD; Derdzinski KA; Chao WR; Frenking G; Loew GH; Jetten AM; Napoli JL; Williams JB; Sani BP
J Med Chem; 1989 Jul; 32(7):1504-17. PubMed ID: 2738885
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.
Boehm MF; Zhang L; Badea BA; White SK; Mais DE; Berger E; Suto CM; Goldman ME; Heyman RA
J Med Chem; 1994 Sep; 37(18):2930-41. PubMed ID: 8071941
[TBL] [Abstract][Full Text] [Related]
3. Discovery and design of retinoic acid receptor and retinoid X receptor class- and subtype-selective synthetic analogs of all-trans-retinoic acid and 9-cis-retinoic acid.
Dawson MI; Zhang XK
Curr Med Chem; 2002 Mar; 9(6):623-37. PubMed ID: 11945128
[TBL] [Abstract][Full Text] [Related]
4. Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.
Jong L; Lehmann JM; Hobbs PD; Harlev E; Huffman JC; Pfahl M; Dawson MI
J Med Chem; 1993 Sep; 36(18):2605-13. PubMed ID: 8410972
[TBL] [Abstract][Full Text] [Related]
5. Novel heteroarotinoids: synthesis and biological activity.
Spruce LW; Gale JB; Berlin KD; Verma AK; Breitman TR; Ji XH; van der Helm D
J Med Chem; 1991 Jan; 34(1):430-9. PubMed ID: 1992144
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.
Beard RL; Chandraratna RA; Colon DF; Gillett SJ; Henry E; Marler DK; Song T; Denys L; Garst ME; Arefieg T
J Med Chem; 1995 Jul; 38(15):2820-9. PubMed ID: 7636843
[TBL] [Abstract][Full Text] [Related]
7. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation.
Lotan R; Dawson MI; Zou CC; Jong L; Lotan D; Zou CP
Cancer Res; 1995 Jan; 55(2):232-6. PubMed ID: 7812950
[TBL] [Abstract][Full Text] [Related]
8. Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).
Flanagan JL; Willhite CC; Ferm VH
J Natl Cancer Inst; 1987 Mar; 78(3):533-8. PubMed ID: 3469465
[TBL] [Abstract][Full Text] [Related]
9. 4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor alpha agonists.
Dawson MI; Jong L; Hobbs PD; Xiao D; Feng KC; Chao WR; Pan C; Fontana JA; Zhang XK
Bioorg Med Chem Lett; 2000 Jun; 10(12):1311-3. PubMed ID: 10890153
[TBL] [Abstract][Full Text] [Related]
10. Retinobenzoic acids. 6. Retinoid antagonists with a heterocyclic ring.
Eyrolles L; Kagechika H; Kawachi E; Fukasawa H; Iijima T; Matsushima Y; Hashimoto Y; Shudo K
J Med Chem; 1994 May; 37(10):1508-17. PubMed ID: 8182710
[TBL] [Abstract][Full Text] [Related]
11. Retinobenzoic acids. 2. Structure-activity relationships of chalcone-4-carboxylic acids and flavone-4'-carboxylic acids.
Kagechika H; Kawachi E; Hashimoto Y; Shudo K
J Med Chem; 1989 Apr; 32(4):834-40. PubMed ID: 2704028
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by retinoids of anthralin-induced mouse epidermal ornithine decarboxylase activity and anthralin-promoted skin tumor formation.
Dawson MI; Chao WR; Helmes CT
Cancer Res; 1987 Dec; 47(23):6210-5. PubMed ID: 3677072
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the inhibitory effects of retinoids on 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activities in CD-1 and Sencar mice.
Chao WR; Helmes CT; Dawson MI
Cancer Lett; 1985 Oct; 29(1):43-8. PubMed ID: 3864525
[TBL] [Abstract][Full Text] [Related]
14. Conformationally restricted retinoids.
Dawson MI; Hobbs PD; Derdzinski K; Chan RL; Gruber J; Chao WR; Smith S; Thies RW; Schiff LJ
J Med Chem; 1984 Nov; 27(11):1516-31. PubMed ID: 6208361
[TBL] [Abstract][Full Text] [Related]
15. 4-Hydroxybenzyl modification of the highly teratogenic retinoid, 4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)-1-propen-1-yl]benzoic acid (TTNPB), yields a compound that induces apoptosis in breast cancer cells and shows reduced teratogenicity.
Anding AL; Nieves NJ; Abzianidze VV; Collins MD; Curley RW; Clagett-Dame M
Chem Res Toxicol; 2011 Nov; 24(11):1853-61. PubMed ID: 21939267
[TBL] [Abstract][Full Text] [Related]
16. Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo.
Oikawa T; Okayasu I; Ashino H; Morita I; Murota S; Shudo K
Eur J Pharmacol; 1993 Nov; 249(1):113-6. PubMed ID: 7506665
[TBL] [Abstract][Full Text] [Related]
17. Retinoidal pyrimidinecarboxylic acids. Unexpected diaza-substituent effects in retinobenzoic acids.
Ohta K; Kawachi E; Inoue N; Fukasawa H; Hashimoto Y; Itai A; Kagechika H
Chem Pharm Bull (Tokyo); 2000 Oct; 48(10):1504-13. PubMed ID: 11045459
[TBL] [Abstract][Full Text] [Related]
18. Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.
Benbrook DM; Madler MM; Spruce LW; Birckbichler PJ; Nelson EC; Subramanian S; Weerasekare GM; Gale JB; Patterson MK; Wang B; Wang W; Lu S; Rowland TC; DiSivestro P; Lindamood C; Hill DL; Berlin KD
J Med Chem; 1997 Oct; 40(22):3567-83. PubMed ID: 9357524
[TBL] [Abstract][Full Text] [Related]
19. Azulenic retinoids: novel nonbenzenoid aromatic retinoids with anticancer activity.
Asato AE; Peng A; Hossain MZ; Mirzadegan T; Bertram JS
J Med Chem; 1993 Oct; 36(21):3137-47. PubMed ID: 8230100
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, tissue distribution and placental permeability of tetrahydro-tetramethyl-naphthalenyl-propenyl benzoic acid (a retinoidal benzoic acid derivative) in hamsters.
Howard WB; Willhite CC; Sharma RP; Omaye ST; Hatori A
Eur J Drug Metab Pharmacokinet; 1989; 14(2):153-9. PubMed ID: 2591420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
